NFKB1 and cancer: In NSCLC cells, carbon ion (12C) radiotherapy combined with PARP-1 inhibitor significantly inhibited NF-kB expression, which followed by reduced MMP-2/9 expressions and significantly suppressed EMT and cancer metastasis (64).